The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension
neomycin and polymyxin B sulfates and hydrocortisone otic · HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL · Suspension · Auricular (Otic) · Preferred Pharmaceuticals, Inc.
NDC 68788-7787-01 · 1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for neomycin and polymyxin b sulfates and hydrocortisone otic (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA060613
- TE code
- AT
- Approval date
- Jan 1, 1982
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of neomycin and polymyxin B sulfates and hydrocortisone otic (Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | HYDROCORTISONE 10 mg/mL; NEOMYCIN SULFATE 3.5 mg/mL; POLYMYXIN B SULFATE 10000 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension — NDC 68788-7787-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68788778701.
Free to cite with attribution — see how the data is put together.